MedPath

Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure

Not Applicable
Completed
Conditions
High Blood Pressure
Interventions
Device: Sticker pads containing lavender and ylang ylang oil
Device: Placebo
Registration Number
NCT05808556
Lead Sponsor
Chulalongkorn University
Brief Summary

The aims of the study were to evaluate efficacy and safety of the sticker pads containing lavender and ylang ylang oil in high blood pressure volunteers

Detailed Description

High blood pressure volunteers were divided into the sticker group or the placebo group. The volunteers attached the pad to their shirt for 3, 7, 10, and 14 days. Blood pressure, pulse rate, adverse reactions, and satisfaction were investigated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • age more than 18 years
  • systolic blood pressure of more than 130 mmHg but less than 160 mmHg or diastolic blood pressure more than 80 mmHg but less than 100 mmHg
  • no hypertensive medicine
  • no dermatological diseases, immunocompromised diseases, seizures, asthma, or respiratory diseases
Exclusion Criteria
  • an unstable condition of other diseases
  • olfactory problems
  • pregnancy
  • lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sticker pads containing lavender and ylang ylang oilSticker pads containing lavender and ylang ylang oilThe subjects in the sticker pad group attached an sticker pad (0.3% lavender oil and 0.7% ylang ylang oil) to their shirt, close to the right side of the neck, for 14 days
Placebo groupPlaceboThe placebo group attached a sticker pad without lavender and ylang ylang oil to their shirt, close to the right side of the neck, for 14 days.
Primary Outcome Measures
NameTimeMethod
Pulse rate14 days

Measure pulse rate in beats/minutes

Systolic blood pressure14 days

Measure systolic blood pressure in mmHg

Diastolic blood pressure14 days

Measure diastolic blood pressure in mmHg

Secondary Outcome Measures
NameTimeMethod
adverse reactions of the respiratory tract, skin, gastrointestinal tract, eye, and central nervous system14 days

Using a score of 0 to 3, following an increase of severity

Satisfaction of the product14 days

Using a visual analogue scale, 0 means not satisfied, 10 means very satisfied

Trial Locations

Locations (1)

Chulalongkorn Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath